|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics. CA Cancer J Clin. 58:71–96. 2008.
|
|
2
|
Kobayashi H, Mochizuki H, Sugihara K, et
al: Characteristics of recurrence and surveillance tools after
curative resection for colorectal cancer: a multicenter study.
Surgery. 141:67–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumour metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jou J and Diehl AM: Epithelial-mesenchymal
transitions and hepatocarcinogenesis. J Clin Invest. 120:1031–1034.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spaderna S, Schmalhofer O, Hlubek F, et
al: A transient, EMT-linked loss of basement membranes indicates
metastasis and poor survival in colorectal cancer.
Gastroenterology. 131:830–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eades G, Yao Y, Yang M, et al: miR-200a
regulates SIRT1 expression and epithelial to mesenchymal transition
(EMT)-like transformation in mammary epithelial cells. J Biol Chem.
286:25992–26002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurashige J, Kamohara H, Watanabe M, et
al: MicroRNA-200b regulates cell proliferation, invasion, and
migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg
Oncol. 19(Suppl 3): S656–S664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eger A, Aigner K, Sonderegger S, et al:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang T, Liu M, Wang C, et al:
Down-regulation of miR-206 promotes proliferation and invasion of
laryngeal cancer by regulating VEGF expression. Anticancer Res.
31:3859–3863. 2011.PubMed/NCBI
|
|
13
|
Wu J, Wu G, Lv L, et al: MicroRNA-34a
inhibits migration and invasion of colon cancer cells via targeting
to Fra-1. Carcinogenesis. 33:519–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gironella M, Seux M, Xie MJ, et al: Tumor
protein 53-induced nuclear protein 1 expression is repressed by
miR-155 and its restoration inhibits pancreatic tumor development.
Proc Natl Acad Sci USA. 104:16170–16175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shibuya H, Iinuma H, Shimada R, et al:
Clinicopathological and prognostic value of microRNA-21 and
microRNA-155 in colorectal cancer. Oncology. 79:313–320. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong W, Yang H, He L, et al: MicroRNA-155
is regulated by the transforming growth factor beta/Smad pathway
and contributes to epithelial cell plasticity by targeting RhoA.
Mol Cell Biol. 28:6773–6784. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bacac M and Stamenkovic I: Metastatic
cancer cell. Annu Rev Pathol. 3:221–247. 2008. View Article : Google Scholar
|
|
20
|
Tsukita S and Furuse M: Claudin-based
barrier in simple and stratified cellular sheets. Curr Opin Cell
Biol. 14:531–536. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ikari A, Takiguchi A, Atomi K, et al:
Decrease in claudin-2 expression enhances cell migration in renal
epithelial Madin-Darby canine kidney cells. J Cell Physiol.
226:1471–1478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoon CH, Kim MJ, Park MJ, et al: Claudin-1
acts through c-Abl-protein kinase CI (PKCI) signaling and has a
causal role in the acquisition of invasive capacity in human liver
cells. J Biol Chem. 285:226–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JW, Hsiao WT, Chen HY, et al:
Up-regulated claudin-1 expression confers resistance to cell death
of nasopharyngeal carcinoma cells. Int J Cancer. 126:1353–1366.
2010.PubMed/NCBI
|
|
24
|
Dhawan P, Singh AB, Deane NG, et al:
Claudin-1 regulates cellular transformation and metastatic or in
colon cancer. J Clin Invest. 115:1765–1776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kinugasa T, Akagi Y, Ochi T, et al:
Increased claudin-1 protein expression in hepatic metastatic
lesions of colorectal cancer. Anticancer Res. 32:2309–2314.
2012.PubMed/NCBI
|
|
26
|
Singh AB, Sharma A, Smith JJ, et al:
Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin
expression in colon cancer cells. Gastroenterology. 141:2140–2153.
2011. View Article : Google Scholar : PubMed/NCBI
|
